Substance list · California
Suggested substance list (page 2)
- Entries
- 1015
- Version date
- 2026-07-31
- Guide
- California
Entries 501 to 1000 of 1015
500 rows
| Substance | English name | CAS | Type | Category | Threshold | Conditions | Valid |
|---|---|---|---|---|---|---|---|
| Herbal remedies containing plant species of the genus Aristolochia | Herbal remedies containing plant species of the genus Aristolochia | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2004-07-09 | CAS column: "---" | ||
| Hexachlorobenzene | Hexachlorobenzene | 118-74-1 | substance | cancer | 0.4 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | |
| Hexachlorobenzene | Hexachlorobenzene | 118-74-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1989-01-01 | |
| Hexachlorobutadiene | Hexachlorobutadiene | 87-68-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2011-05-03 | |
| Hexachlorocyclohexane (technical grade) | Hexachlorocyclohexane (technical grade) | other | cancer | 0.2 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | CAS column: "---" | ||
| Hexachlorocyclohexane (alpha isomer) | Hexachlorocyclohexane (alpha isomer) | other | cancer | 0.3 µg/day (NSRL or MADL) | Sub entry under "Hexachlorocyclohexane (technical grade)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | ||
| Hexachlorocyclohexane (beta isomer) | Hexachlorocyclohexane (beta isomer) | other | cancer | 0.5 µg/day (NSRL or MADL) | Sub entry under "Hexachlorocyclohexane (technical grade)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | ||
| Hexachlorocyclohexane (gamma isomer) | Hexachlorocyclohexane (gamma isomer) | other | cancer | 0.6 µg/day (NSRL or MADL) | Sub entry under "Hexachlorocyclohexane (technical grade)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | ||
| Hexachlorodibenzodioxin | Hexachlorodibenzodioxin | 34465-46- 8 | substance | cancer | 0.0002 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Hexachloroethane | Hexachloroethane | 67-72-1 | substance | cancer | 20 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-07-01 | |
| 2,4-Hexadienal (89% trans, trans isomer; 11% cis, trans isomer) | 2,4-Hexadienal (89% trans, trans isomer; 11% cis, trans isomer) | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2005-03-04 | CAS column: "---" | ||
| Hexafluoroacetone [Basis for listing changed effective June 6, 2014] | Hexafluoroacetone [Basis for listing changed effective June 6, 2014] | 684-16-2 | substance | developmental, male | µg/day (NSRL or MADL) | Listing mechanism: LC SQE; Date listed: 2008-08-01 | |
| Hexamethylphosphoramide | Hexamethylphosphoramide | 680-31-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Hexamethylphosphoramide | Hexamethylphosphoramide | 680-31-9 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1994-10-01 | |
| n-Hexane | n-Hexane | 110-54-3 | substance | male | 28,000 (oral) 20,000 (inhalation) µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2017-12-15 | |
| 2,5-Hexanedione | 2,5-Hexanedione | 110-13-4 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2015-12-04 | |
| Histrelin acetate | Histrelin acetate | other | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1998-05-15 | CAS column: "---" | ||
| Hydramethylnon | Hydramethylnon | 67485-29-4 | substance | developmental, male | 120 (oral) µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-03-05 | |
| Hydrazine | Hydrazine | 302-01-2 | substance | cancer | 0.04 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Hydrazine sulfate | Hydrazine sulfate | 10034-93-2 | substance | cancer | 0.2 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Hydrazobenzene (1,2-Diphenylhydrazine) | Hydrazobenzene (1,2-Diphenylhydrazine) | 122-66-7 | substance | cancer | 0.8 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Hydrochlorothiazide | Hydrochlorothiazide | 58-93-5; 125727-50-6; 8049-49-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2026-07-17 | |
| Hydrogen cyanide (HCN) and cyanide salts (CN salts) | Hydrogen cyanide (HCN) and cyanide salts (CN salts) | group | male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2013-07-05 | CAS column: "---" | ||
| Cyanide salts that readily dissociate in solution (expressed as cyanide) | Cyanide salts that readily dissociate in solution (expressed as cyanide) | group | male | 9.8 µg/day (NSRL or MADL) | Sub entry under "Hydrogen cyanide (HCN) and cyanide salts (CN salts)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | f: Hydrogen cyanide and cyanide salts MADLs were adopted on August 7, 2013, effective October 1, 2013. | ||
| Hydrogen cyanide | Hydrogen cyanide | other | male | 10 (oral) µg/day (NSRL or MADL) | Sub entry under "Hydrogen cyanide (HCN) and cyanide salts (CN salts)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | f: Hydrogen cyanide and cyanide salts MADLs were adopted on August 7, 2013, effective October 1, 2013. | ||
| Sodium cyanide | Sodium cyanide | other | male | 19 (oral) µg/day (NSRL or MADL) | Sub entry under "Hydrogen cyanide (HCN) and cyanide salts (CN salts)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | f: Hydrogen cyanide and cyanide salts MADLs were adopted on August 7, 2013, effective October 1, 2013. | ||
| Potassium cyanide | Potassium cyanide | other | male | 25 (oral) µg/day (NSRL or MADL) | Sub entry under "Hydrogen cyanide (HCN) and cyanide salts (CN salts)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | f: Hydrogen cyanide and cyanide salts MADLs were adopted on August 7, 2013, effective October 1, 2013. | ||
| 1-Hydroxyanthraquinone | 1-Hydroxyanthraquinone | 129-43-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2005-05-27 | |
| Hydroxyurea | Hydroxyurea | 127-07-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1997-05-01 | |
| Idarubicin hydrochloride | Idarubicin hydrochloride | 57852-57-0 | substance | developmental, male | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-08-20 | |
| Ifosfamide | Ifosfamide | 3778-73-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Iodine-131 | Iodine-131 | 10043-66-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1989-01-01 | |
| Imazalil | Imazalil | 35554-44-0 | substance | cancer | 11 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2011-05-20 | |
| Indeno[1,2,3-cd]pyrene | Indeno[1,2,3-cd]pyrene | 193-39-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Indium phosphide | Indium phosphide | 22398-80-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2001-02-27 | |
| Indium tin oxide | Indium tin oxide | 50926-11-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2021-03-19 | |
| IQ (2-Amino-3-methylimidazo[4,5-f] quinoline) | IQ (2-Amino-3-methylimidazo[4,5-f] quinoline) | 76180-96-6 | substance | cancer | 0.5 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-04-01 | |
| Iprodione | Iprodione | 36734-19-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1996-05-01 | |
| Iprovalicarb | Iprovalicarb | 140923-17-7/ 140923-25-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2007-06-01 | |
| Iron dextran complex | Iron dextran complex | 9004-66-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Isobutyl nitrite | Isobutyl nitrite | 542-56-3 | substance | cancer | 7.4 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1996-05-01 | |
| Isoprene | Isoprene | 78-79-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1996-05-01 | |
| Isopyrazam | Isopyrazam | 881685-58-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2012-07-24 | |
| Isosafrole | Isosafrole | 120-58-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | Delisted: December 8, 2006 | until 2006-12-08 |
| Isotretinoin | Isotretinoin | 4759-48-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-07-01 | |
| Isoxaflutole | Isoxaflutole | 141112-29-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2000-12-22 | |
| Kresoxim-methyl | Kresoxim-methyl | 143390-89-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2012-02-03 | |
| Lactofen | Lactofen | 77501-63-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1989-01-01 | |
| Lasiocarpine | Lasiocarpine | 303-34-4 | substance | cancer | 0.09 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Lead [Basis for listing changed effective November 22, 2013] | Lead [Basis for listing changed effective November 22, 2013] | other | developmental, female, male | 0.5 µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1987-02-27 | CAS column: "---" | ||
| Lead and lead compounds | Lead and lead compounds | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1992-10-01 | CAS column: "---" | ||
| Lead | Lead | other | cancer | 15 (oral) µg/day (NSRL or MADL) | Sub entry under "Lead and lead compounds" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | ||
| Lead acetate | Lead acetate | 301-04-2 | substance | cancer | 23 (oral) µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Lead phosphate | Lead phosphate | 7446-27-7 | substance | cancer | 58 (oral) µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Lead subacetate | Lead subacetate | 1335-32-6 | substance | cancer | 41 (oral) µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Leather dust | Leather dust | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2011-04-29 | CAS column: "---" | ||
| Leucomalachite green | Leucomalachite green | 129-73-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2023-04-21 | |
| Leuprolide acetate | Leuprolide acetate | 74381-53-6 | substance | developmental, female, male | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1997-08-26 | |
| Levodopa | Levodopa | 59-92-7 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-01-29 | |
| Levonorgestrel implants | Levonorgestrel implants | 797-63-7 | substance | female | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1998-05-15 | |
| Lindane and other hexachlorocyclohexane isomers | Lindane and other hexachlorocyclohexane isomers | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | CAS column: "---" | ||
| Linuron | Linuron | 330-55-2 | substance | developmental | 460 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-03-19 | |
| Lithium carbonate | Lithium carbonate | 554-13-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-01-01 | |
| Lithium citrate | Lithium citrate | 919-16-4 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-01-01 | |
| Lorazepam | Lorazepam | 846-49-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Lovastatin | Lovastatin | 75330-75-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-10-01 | |
| Lynestrenol | Lynestrenol | 52-76-6 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2001-02-27 | |
| Malathion | Malathion | 121-75-5 | substance | cancer | 180 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2016-05-20 | |
| Malonaldehyde, sodium salt | Malonaldehyde, sodium salt | 24382-04-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2011-05-03 | |
| Mancozeb | Mancozeb | 8018-01-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| Maneb | Maneb | 12427-38-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| Marijuana smoke | Marijuana smoke | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2009-06-19 | CAS column: "---" | ||
| Me-A-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole) | Me-A-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole) | 68006-83-7 | substance | cancer | 0.6 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| Mebendazole | Mebendazole | 31431-39-7 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-08-20 | |
| Medroxyprogesterone acetate | Medroxyprogesterone acetate | 71-58-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| Medroxyprogesterone acetate | Medroxyprogesterone acetate | 71-58-9 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Megestrol acetate | Megestrol acetate | 595-33-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 2014-03-28 | |
| Megestrol acetate | Megestrol acetate | 595-33-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-01-01 | |
| MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) | MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) | 77094-11-2 | substance | cancer | 0.46 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1994-10-01 | |
| MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) | MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) | 77500-04-0 | substance | cancer | 0.41 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1994-10-01 | |
| Melphalan | Melphalan | 148-82-3 | substance | cancer | 0.005 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1987-02-27 | |
| Melphalan | Melphalan | 148-82-3 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Menotropins | Menotropins | 9002-68-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Mepanipyrim | Mepanipyrim | 110235-47-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2008-07-01 | |
| Meprobamate | Meprobamate | 57-53-4 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-01-01 | |
| 2‑Mercaptobenzothiazole | 2‑Mercaptobenzothiazole | 149-30-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2017-10-27 | |
| Mercaptopurine | Mercaptopurine | 6112-76-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Mercury and mercury compounds | Mercury and mercury compounds | group | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-07-01 | CAS column: "---" | ||
| Merphalan | Merphalan | 531-76-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Mestranol | Mestranol | 72-33-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Metam potassium | Metam potassium | 137-41-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2010-12-31 | |
| Methacycline hydrochloride | Methacycline hydrochloride | 3963-95-9 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-01-01 | |
| Metham sodium | Metham sodium | 137-42-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-11-06 | |
| Metham sodium | Metham sodium | 137-42-8 | substance | developmental | 290 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-05-15 | |
| Methanol | Methanol | 67-56-1 | substance | developmental | 47,000 (inhalation) 23,000 (oral) µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2012-03-16 | |
| Methazole | Methazole | 20354-26-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-12-01 | |
| Methimazole | Methimazole | 60-56-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Methotrexate | Methotrexate | 59-05-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1989-01-01 | |
| Methotrexate sodium | Methotrexate sodium | 15475-56-6 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| 5-Methoxypsoralen with ultraviolet A therapy | 5-Methoxypsoralen with ultraviolet A therapy | 484-20-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-10-01 | |
| 8-Methoxypsoralen with ultraviolet A therapy | 8-Methoxypsoralen with ultraviolet A therapy | 298-81-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1987-02-27 | |
| Methyl acrylate | Methyl acrylate | 96-33-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2021-12-17 | |
| 2-Methylaziridine (Propyleneimine) | 2-Methylaziridine (Propyleneimine) | 75-55-8 | substance | cancer | 0.028 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Methylazoxymethanol | Methylazoxymethanol | 590-96-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Methylazoxymethanol acetate | Methylazoxymethanol acetate | 592-62-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Methyl bromide, as a structural fumigant | Methyl bromide, as a structural fumigant | 74-83-9 | substance | developmental | 810 (inhalation) µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1993-01-01 | |
| Methyl carbamate | Methyl carbamate | 598-55-0 | substance | cancer | 160 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-05-15 | |
| Methyl chloride | Methyl chloride | 74-87-3 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2000-03-10 | |
| Methyl chloride [Basis for listing changed effective March 7, 2014] | Methyl chloride [Basis for listing changed effective March 7, 2014] | 74-87-3 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2009-08-07 | |
| 3-Methylcholanthrene | 3-Methylcholanthrene | 56-49-5 | substance | cancer | 0.03 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| 5-Methylchrysene | 5-Methylchrysene | 3697-24-3 | substance | cancer | 0.0084 (oral) µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| 4,4'-Methylene bis(2-chloroaniline) | 4,4'-Methylene bis(2-chloroaniline) | 101-14-4 | substance | cancer | 0.5 µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1987-07-01 | |
| 4,4'-Methylene bis(N,N-dimethyl)benzenamine | 4,4'-Methylene bis(N,N-dimethyl)benzenamine | 101-61-1 | substance | cancer | 20 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| 4,4'-Methylene bis(2-methylaniline) | 4,4'-Methylene bis(2-methylaniline) | 838-88-0 | substance | cancer | 0.8 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| 4,4'-Methylenedianiline | 4,4'-Methylenedianiline | 101-77-9 | substance | cancer | 0.4 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| 4,4'-Methylenedianiline dihydrochloride | 4,4'-Methylenedianiline dihydrochloride | 13552-44-8 | substance | cancer | 0.6 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Methyleugenol | Methyleugenol | 93-15-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2001-11-16 | |
| Methylhydrazine and its salts | Methylhydrazine and its salts | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1992-07-01 | CAS column: "---" | ||
| Methylhydrazine | Methylhydrazine | other | cancer | 0.058 (oral) 0.090 (inhalation) µg/day (NSRL or MADL) | Sub entry under "Methylhydrazine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | ||
| Methylhydrazine sulfate | Methylhydrazine sulfate | other | cancer | 0.18 µg/day (NSRL or MADL) | Sub entry under "Methylhydrazine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | ||
| 2-Methylimidazole | 2-Methylimidazole | 693-98-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2012-06-22 | |
| 4-Methylimidazole | 4-Methylimidazole | 822-36-6 | substance | cancer | 29 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2011-01-07 | |
| Methyl iodide | Methyl iodide | 74-88-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Methyl isobutyl ketone | Methyl isobutyl ketone | 108-10-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2011-11-04 | |
| Methyl isobutyl ketone (MIBK) | Methyl isobutyl ketone (MIBK) | 108-10-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2014-03-28 | |
| Methyl isocyanate (MIC) | Methyl isocyanate (MIC) | 624-83-9 | substance | developmental, female | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2010-11-12 | |
| Methyl isopropyl ketone | Methyl isopropyl ketone | 563-80-4 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2012-02-17 | Delisted: April 4, 2014 | until 2014-04-04 |
| Methyl mercury | Methyl mercury | other | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-07-01 | CAS column: "---" | ||
| Methylmercury compounds | Methylmercury compounds | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1996-05-01 | CAS column: "---" | ||
| Methyl methanesulfonate | Methyl methanesulfonate | 66-27-3 | substance | cancer | 7 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Methyl-n-butyl ketone | Methyl-n-butyl ketone | 591-78-6 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2015-12-04 | |
| Methyl-n-butyl ketone [Basis for listing changed effective November 9, 2015] | Methyl-n-butyl ketone [Basis for listing changed effective November 9, 2015] | 591-78-6 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2009-08-07 | |
| 2-Methyl-1-nitroanthraquinone (of uncertain purity) | 2-Methyl-1-nitroanthraquinone (of uncertain purity) | 129-15-7 | substance | cancer | 0.2 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| N-Methyl-N-Formylhydrazine | N-Methyl-N-Formylhydrazine | 758-17-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2025-12-08 | |
| N-Methyl-N'-nitro-N-nitrosoguanidine | N-Methyl-N'-nitro-N-nitrosoguanidine | 70-25-7 | substance | cancer | 0.08 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| N-Methylolacrylamide | N-Methylolacrylamide | 924-42-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-07-01 | |
| N-Methylpyrrolidone | N-Methylpyrrolidone | 872-50-4 | substance | developmental | 3200 (inhalation) 17000 (dermal) µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2001-06-15 | |
| α-Methyl styrene (alpha-Methylstyrene) | α-Methyl styrene (alpha-Methylstyrene) | 98-83-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2012-11-02 | |
| α-Methyl styrene | α-Methyl styrene | 98-83-9 | substance | female | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2011-07-29 | Delisted: April 4, 2014 | until 2014-04-04 |
| Methyltestosterone | Methyltestosterone | 58-18-4 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Methylthiouracil | Methylthiouracil | 56-04-2 | substance | cancer | 2 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Metiram | Metiram | 9006-42-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| Metiram | Metiram | 9006-42-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-03-30 | |
| Metronidazole | Metronidazole | 443-48-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Michler's ketone | Michler's ketone | 90-94-8 | substance | cancer | 0.8 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Midazolam hydrochloride | Midazolam hydrochloride | 59467-96-8 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Minocycline hydrochloride (internal use) | Minocycline hydrochloride (internal use) | 13614-98-7 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-01-01 | |
| Mirex | Mirex | 2385-85-5 | substance | cancer | 0.04 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Misoprostol | Misoprostol | 59122-46-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Mitomycin C | Mitomycin C | 50-07-7 | substance | cancer | 0.00009 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Mitoxantrone hydrochloride | Mitoxantrone hydrochloride | 70476-82-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 2015-01-23 | |
| Mitoxantrone hydrochloride | Mitoxantrone hydrochloride | 70476-82-3 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Molinate | Molinate | 2212-67-1 | substance | developmental, female, male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2009-12-11 | |
| Molybdenum trioxide | Molybdenum trioxide | 1313-27-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2021-03-19 | |
| MON 4660 (dichloroacetyl-1-oxa-4-azaspiro(4,5)-decane | MON 4660 (dichloroacetyl-1-oxa-4-azaspiro(4,5)-decane | 71526-07-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2011-03-22 | |
| MON 13900 (furilazole) | MON 13900 (furilazole) | 121776-33-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2011-03-22 | |
| 3-Monochloropropane-1,2-diol (3-MCPD) | 3-Monochloropropane-1,2-diol (3-MCPD) | 96-24-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2010-10-08 | |
| Monocrotaline | Monocrotaline | 315-22-0 | substance | cancer | 0.07 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture) | MOPP (vincristine-prednisone-nitrogen mustard-procarbazine mixture) | 113803-47-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2011-11-04 | |
| 5-(Morpholinomethyl)-3-[(5-nitrofurfuryl-idene)-amino]-2-oxazolidinone | 5-(Morpholinomethyl)-3-[(5-nitrofurfuryl-idene)-amino]-2-oxazolidinone | 139-91-3 | substance | cancer | 0.18 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Mustard Gas | Mustard Gas | 505-60-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1987-02-27 | |
| MX (3-chloro-4-dichloromethyl-5-hydroxy-2(5H)-furanone) | MX (3-chloro-4-dichloromethyl-5-hydroxy-2(5H)-furanone) | 77439-76-0 | substance | cancer | 0.11 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2000-12-22 | |
| Myclobutanil | Myclobutanil | 88671-89-0 | substance | developmental, male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-04-16 | |
| beta-Myrcene | beta-Myrcene | 123-35-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2015-03-27 | |
| Nabam | Nabam | 142-59-6 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-03-30 | |
| Nafarelin acetate | Nafarelin acetate | 86220-42-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Nafenopin | Nafenopin | 3771-19-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Nalidixic acid | Nalidixic acid | 389-08-2 | substance | cancer | 28 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-05-15 | |
| Naphthalene | Naphthalene | 91-20-3 | substance | cancer | 5.8 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2002-04-19 | |
| 1-Naphthylamine | 1-Naphthylamine | 134-32-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| 2-Naphthylamine | 2-Naphthylamine | 91-59-8 | substance | cancer | 0.4 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1987-02-27 | |
| Neomycin sulfate (internal use) | Neomycin sulfate (internal use) | 1405-10-3 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-10-01 | |
| Netilmicin sulfate | Netilmicin sulfate | 56391-57-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Nickel (Metallic) | Nickel (Metallic) | 7440-02-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Nickel acetate | Nickel acetate | 373-02-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Nickel carbonate | Nickel carbonate | 3333-67-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Nickel carbonyl | Nickel carbonyl | 13463-39-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | |
| Nickel carbonyl | Nickel carbonyl | 13463-39-3 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1996-09-01 | |
| Nickel compounds | Nickel compounds | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2004-05-07 | CAS column: "---" | ||
| Nickel (soluble compounds) | Nickel (soluble compounds) | group | developmental, male | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2018-10-26 | CAS column: "---" | ||
| Nickel hydroxide | Nickel hydroxide | 12054-48-7; 12125-56-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Nickelocene | Nickelocene | 1271-28-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Nickel oxide | Nickel oxide | 1313-99-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Nickel refinery dust from the pyrometallurgical process | Nickel refinery dust from the pyrometallurgical process | other | cancer | 0.8 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | CAS column: "---" | ||
| Nickel subsulfide | Nickel subsulfide | 12035-72-2 | substance | cancer | 0.4 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | |
| Nicotine | Nicotine | 54-11-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Nifedipine | Nifedipine | 21829-25-4 | substance | developmental, female, male | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-01-29 | |
| Nimodipine | Nimodipine | 66085-59-4 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 2001-04-24 | |
| Niridazole | Niridazole | 61-57-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Nitrapyrin [Basis for listing changed effective on November 4, 2015] | Nitrapyrin [Basis for listing changed effective on November 4, 2015] | 1929-82-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2005-10-05 | |
| Nitrapyrin | Nitrapyrin | 1929-82-4 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-03-30 | |
| Nitrilotriacetic acid | Nitrilotriacetic acid | 139-13-9 | substance | cancer | 100 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Nitrilotriacetic acid, trisodium salt monohydrate | Nitrilotriacetic acid, trisodium salt monohydrate | 18662-53-8 | substance | cancer | 70 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1989-04-01 | |
| 5-Nitroacenaphthene | 5-Nitroacenaphthene | 602-87-9 | substance | cancer | 6 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| 5-Nitro-o-anisidine | 5-Nitro-o-anisidine | 99-59-2 | substance | cancer | 10 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | Delisted: December 8, 2006 | until 2006-12-08 |
| o-Nitroanisole | o-Nitroanisole | 91-23-6 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1992-10-01 | |
| para-Nitroanisole | para-Nitroanisole | 100-17-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2019-09-13 | |
| Nitrobenzene | Nitrobenzene | 98-95-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1997-08-26 | |
| Nitrobenzene | Nitrobenzene | 98-95-3 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2010-03-30 | |
| 4-Nitrobiphenyl | 4-Nitrobiphenyl | 92-93-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| 6-Nitrochrysene | 6-Nitrochrysene | 7496-02-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-10-01 | |
| Nitrofen (technical grade) | Nitrofen (technical grade) | 1836-75-5 | substance | cancer | 9 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| 2-Nitrofluorene | 2-Nitrofluorene | 607-57-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-10-01 | |
| Nitrofurantoin | Nitrofurantoin | 67-20-9 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1991-04-01 | |
| Nitrofurazone | Nitrofurazone | 59-87-0 | substance | cancer | 0.5 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| 1-[(5-Nitrofurfurylidene)-amino]-2-imidazolidinone | 1-[(5-Nitrofurfurylidene)-amino]-2-imidazolidinone | 555-84-0 | substance | cancer | 0.4 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide | N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide | 531-82-8 | substance | cancer | 0.5 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Nitrogen mustard (Mechlorethamine) | Nitrogen mustard (Mechlorethamine) | 51-75-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Nitrogen mustard (Mechlorethamine) | Nitrogen mustard (Mechlorethamine) | 51-75-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1989-01-01 | |
| Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) | Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) | 55-86-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) | Nitrogen mustard hydrochloride (Mechlorethamine hydrochloride) | 55-86-7 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Nitrogen mustard N-oxide | Nitrogen mustard N-oxide | 126-85-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Nitrogen mustard N-oxide hydrochloride | Nitrogen mustard N-oxide hydrochloride | 302-70-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Nitromethane | Nitromethane | 75-52-5 | substance | cancer | 39 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1997-05-01 | |
| 2-Nitropropane | 2-Nitropropane | 79-46-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| 1-Nitropyrene | 1-Nitropyrene | 5522-43-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-10-01 | |
| 4-Nitropyrene | 4-Nitropyrene | 57835-92-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-10-01 | |
| N-Nitrosodi-n-butylamine | N-Nitrosodi-n-butylamine | 924-16-3 | substance | cancer | 0.06 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | |
| N-Nitrosodiethanolamine | N-Nitrosodiethanolamine | 1116-54-7 | substance | cancer | 0.3 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| N-Nitrosodiethylamine | N-Nitrosodiethylamine | 55-18-5 | substance | cancer | 0.02 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | |
| N-Nitrosodimethylamine | N-Nitrosodimethylamine | 62-75-9 | substance | cancer | 0.04 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | |
| p-Nitrosodiphenylamine | p-Nitrosodiphenylamine | 156-10-5 | substance | cancer | 30 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| N-Nitrosodiphenylamine | N-Nitrosodiphenylamine | 86-30-6 | substance | cancer | 80 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| N-Nitrosodi-n-propylamine | N-Nitrosodi-n-propylamine | 621-64-7 | substance | cancer | 0.1 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| N-Nitroso-N-ethylurea | N-Nitroso-N-ethylurea | 759-73-9 | substance | cancer | 0.03 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | |
| N-Nitrosohexamethyleneimine | N-Nitrosohexamethyleneimine | 932-83-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2018-11-23 | |
| 3-(N-Nitrosomethylamino) propionitrile | 3-(N-Nitrosomethylamino) propionitrile | 60153-49-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-04-01 | |
| 4-(N-Nitrosomethylamino)-1-(3-pyridyl)1-butanone | 4-(N-Nitrosomethylamino)-1-(3-pyridyl)1-butanone | 64091-91-4 | substance | cancer | 0.014 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-04-01 | |
| N-Nitrosomethyl-n-butylamine | N-Nitrosomethyl-n-butylamine | 7068-83-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitrosomethyl-n-decylamine | N-Nitrosomethyl-n-decylamine | 75881-22-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitrosomethyl-n-dodecylamine | N-Nitrosomethyl-n-dodecylamine | 55090-44-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitrosomethylethylamine | N-Nitrosomethylethylamine | 10595-95-6 | substance | cancer | 0.03 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| N-Nitrosomethyl-n-heptylamine | N-Nitrosomethyl-n-heptylamine | 16338-99-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitrosomethyl-n-hexylamine | N-Nitrosomethyl-n-hexylamine | 28538-70-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitrosomethyl-n-nonylamine | N-Nitrosomethyl-n-nonylamine | 75881-19-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitrosomethyl-n-octylamine | N-Nitrosomethyl-n-octylamine | 34423-54-6 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitrosomethyl-n-pentylamine | N-Nitrosomethyl-n-pentylamine | 13256-07-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitrosomethyl-n-propylamine | N-Nitrosomethyl-n-propylamine | 924-46-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitrosomethyl-n-tetradecylamine | N-Nitrosomethyl-n-tetradecylamine | 75881-20-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitrosomethyl-n-undecylamine | N-Nitrosomethyl-n-undecylamine | 68107-26-6 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2014-12-26 | |
| N-Nitroso-N-methylurea | N-Nitroso-N-methylurea | 684-93-5 | substance | cancer | 0.006 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | |
| N-Nitroso-N-methylurethane | N-Nitroso-N-methylurethane | 615-53-2 | substance | cancer | 0.006 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| N-Nitrosomethylvinylamine | N-Nitrosomethylvinylamine | 4549-40-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| N-Nitrosomorpholine | N-Nitrosomorpholine | 59-89-2 | substance | cancer | 0.1 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| N-Nitrosonornicotine | N-Nitrosonornicotine | 16543-55-8 | substance | cancer | 0.5 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| N-Nitrosopiperidine | N-Nitrosopiperidine | 100-75-4 | substance | cancer | 0.07 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| N-Nitrosopyrrolidine | N-Nitrosopyrrolidine | 930-55-2 | substance | cancer | 0.3 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-10-01 | |
| N-Nitrososarcosine | N-Nitrososarcosine | 13256-22-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| o-Nitrotoluene | o-Nitrotoluene | 88-72-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-05-15 | |
| Nitrous oxide [Basis for listing changed effective November 8, 2013] | Nitrous oxide [Basis for listing changed effective November 8, 2013] | 10024-97-2 | substance | developmental, female | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2008-08-01 | |
| Norethisterone (Norethindrone) | Norethisterone (Norethindrone) | 68-22-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Norethisterone (Norethindrone) | Norethisterone (Norethindrone) | 68-22-4 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Norethisterone acetate (Norethindrone acetate) | Norethisterone acetate (Norethindrone acetate) | 51-98-9 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-10-01 | |
| Norethisterone (Norethindrone) /Ethinyl estradiol | Norethisterone (Norethindrone) /Ethinyl estradiol | 68-22-4/ 57-63-6 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Norethisterone (Norethindrone) /Mestranol | Norethisterone (Norethindrone) /Mestranol | 68-22-4/ 72-33-3 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Norethynodrel | Norethynodrel | 68-23-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2001-02-27 | |
| Norgestrel | Norgestrel | 6533-00-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Ochratoxin A | Ochratoxin A | 303-47-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-07-01 | |
| Oil Orange SS | Oil Orange SS | 2646-17-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Oral contraceptives, combined | Oral contraceptives, combined | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | CAS column: "---" | ||
| Oral contraceptives, sequential | Oral contraceptives, sequential | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | CAS column: "---" | ||
| Oryzalin | Oryzalin | 19044-88-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2008-09-12 | |
| Oxadiazon | Oxadiazon | 19666-30-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1991-07-01 | |
| Oxadiazon | Oxadiazon | 19666-30-9 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-05-15 | |
| Oxazepam | Oxazepam | 604-75-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1994-10-01 | |
| Oxazepam | Oxazepam | 604-75-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-10-01 | |
| p,p'-Oxybis(benzenesulfonyl hydrazide) | p,p'-Oxybis(benzenesulfonyl hydrazide) | 80-51-3 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2009-08-07 | Delisted: December 13, 2013 | until 2013-12-13 |
| Oxydemeton methyl | Oxydemeton methyl | 301-12-2 | substance | female, male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-11-06 | |
| Oxymetholone | Oxymetholone | 434-07-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Oxymetholone | Oxymetholone | 434-07-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1997-05-01 | |
| Oxytetracycline (internal use) | Oxytetracycline (internal use) | 79-57-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-01-01 | |
| Oxytetracycline hydrochloride (internal use) | Oxytetracycline hydrochloride (internal use) | 2058-46-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-10-01 | |
| Oxythioquinox (Chinomethionat) | Oxythioquinox (Chinomethionat) | 2439-01-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-08-20 | |
| Oxythioquinox (Chinomethionat) | Oxythioquinox (Chinomethionat) | 2439-01-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-11-06 | |
| Paclitaxel | Paclitaxel | 33069-62-4 | substance | developmental, female, male | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1997-08-26 | |
| Palygorskite fibers (> 5µm in length) | Palygorskite fibers (> 5µm in length) | 12174-11-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-12-28 | |
| Panfuran S | Panfuran S | 794-93-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Paramethadione | Paramethadione | 115-67-3 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Parathion | Parathion | 56-38-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2016-05-20 | |
| Penicillamine | Penicillamine | 52-67-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-01-01 | |
| pentabromodiphenyl ether mixture [DE-71 (technical grade)] | pentabromodiphenyl ether mixture [DE-71 (technical grade)] | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2017-07-07 | CAS column: "---" | ||
| Pentachlorophenol | Pentachlorophenol | 87-86-5 | substance | cancer | 40 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| Pentachlorophenol and by-products of its synthesis (complex mixture) | Pentachlorophenol and by-products of its synthesis (complex mixture) | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2016-10-21 | CAS column: "---" | ||
| Pentobarbital sodium | Pentobarbital sodium | 57-33-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Pentosan polysulfate sodium | Pentosan polysulfate sodium | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2014-04-18 | CAS column: "---" | ||
| Pentostatin | Pentostatin | 53910-25-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1996-09-01 | |
| Perfluorononanoic acid (PFNA) and its salts | Perfluorononanoic acid (PFNA) and its salts | group | male | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2021-12-31 | CAS column: "---" | ||
| Perfluorooctane sulfonate (PFOS) | Perfluorooctane sulfonate (PFOS) | 1763-23-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2017-11-10 | |
| Perfluorooctane sulfonic acid (PFOS) and its salts and transformation and degradation precursors | Perfluorooctane sulfonic acid (PFOS) and its salts and transformation and degradation precursors | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2021-12-24 | CAS column: "---" | ||
| Perfluorooctanoic acid (PFOA) | Perfluorooctanoic acid (PFOA) | 335-67-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2022-02-25 | |
| Perfluorooctanoic acid (PFOA) | Perfluorooctanoic acid (PFOA) | 335-67-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2017-11-10 | |
| Pertuzumab | Pertuzumab | 380610-27-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 2017-01-27 | |
| Phenacemide | Phenacemide | 63-98-9 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Phenacetin | Phenacetin | 62-44-2 | substance | cancer | 300 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Phenazopyridine | Phenazopyridine | 94-78-0 | substance | cancer | 4 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Phenazopyridine hydrochloride | Phenazopyridine hydrochloride | 136-40-3 | substance | cancer | 5 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Phenesterin | Phenesterin | 3546-10-9 | substance | cancer | 0.005 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1989-07-01 | |
| Phenobarbital | Phenobarbital | 50-06-6 | substance | cancer | 2 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| Phenolphthalein | Phenolphthalein | 77-09-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-05-15 | |
| Phenoxybenzamine | Phenoxybenzamine | 59-96-1 | substance | cancer | 0.2 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Phenoxybenzamine hydrochloride | Phenoxybenzamine hydrochloride | 63-92-3 | substance | cancer | 0.3 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Phenprocoumon | Phenprocoumon | 435-97-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-10-01 | |
| o-Phenylenediamine and its salts | o-Phenylenediamine and its salts | 95-54-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-05-15 | |
| o-Phenylenediamine | o-Phenylenediamine | other | cancer | 26 µg/day (NSRL or MADL) | Sub entry under "o-Phenylenediamine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | ||
| o-Phenylenediamine dihydrochloride | o-Phenylenediamine dihydrochloride | other | cancer | 44 µg/day (NSRL or MADL) | Sub entry under "o-Phenylenediamine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | ||
| Phenyl glycidyl ether | Phenyl glycidyl ether | 122-60-1 | substance | cancer | 5 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-10-01 | |
| Phenyl glycidyl ether | Phenyl glycidyl ether | 122-60-1 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2009-08-07 | Delisted: April 4, 2014 | Shown in strikeout in the xlsx | until 2014-04-04 |
| Phenylhydrazine and its salts | Phenylhydrazine and its salts | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1992-07-01 | CAS column: "---" | ||
| Phenylhydrazine | Phenylhydrazine | other | cancer | 1 µg/day (NSRL or MADL) | Sub entry under "Phenylhydrazine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | ||
| Phenylhydrazine hydrochloride | Phenylhydrazine hydrochloride | other | cancer | 1.4 µg/day (NSRL or MADL) | Sub entry under "Phenylhydrazine and its salts" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | ||
| o-Phenylphenate, sodium | o-Phenylphenate, sodium | 132-27-4 | substance | cancer | 200 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| o-Phenylphenol | o-Phenylphenol | 90-43-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2000-08-04 | |
| Phenylphosphine [Basis for listing changed effective June 6, 2014] | Phenylphosphine [Basis for listing changed effective June 6, 2014] | 638-21-1 | substance | developmental male | µg/day (NSRL or MADL) | Listing mechanism: LC SQE; Date listed: 2009-08-07 | |
| PhiP(2-Amino-1-methyl-6-phenylimidazol[4,5-b]pyridine) | PhiP(2-Amino-1-methyl-6-phenylimidazol[4,5-b]pyridine) | 105650-23-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1994-10-01 | |
| Pimozide | Pimozide | 2062-78-4 | substance | developmental, female | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-08-20 | |
| Pioglitazone | Pioglitazone | 111025-46-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2014-04-18 | |
| Pipobroman | Pipobroman | 54-91-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Pirimicarb | Pirimicarb | 23103-98-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2008-07-01 | |
| Plicamycin | Plicamycin | 18378-89-7 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Polybrominated biphenyls | Polybrominated biphenyls | other | cancer | 0.02 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | CAS column: "---" | ||
| Polybrominated biphenyls | Polybrominated biphenyls | other | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1994-10-01 | CAS column: "---" | ||
| Polychlorinated biphenyls | Polychlorinated biphenyls | other | cancer | 0.09 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | CAS column: "---" | ||
| Polychlorinated biphenyls | Polychlorinated biphenyls | other | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1991-01-01 | CAS column: "---" | ||
| Polychlorinated biphenyls (containing 60 or more percent chlorine by molecular weight) | Polychlorinated biphenyls (containing 60 or more percent chlorine by molecular weight) | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | CAS column: "---" | ||
| Polychlorinated dibenzo-p-dioxins | Polychlorinated dibenzo-p-dioxins | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---" | ||
| Polychlorinated dibenzofurans | Polychlorinated dibenzofurans | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---" | ||
| Polygeenan | Polygeenan | 53973-98-1 | substance | cancer | 1200 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Ponceau MX | Ponceau MX | 3761-53-3 | substance | cancer | 200 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Ponceau 3R | Ponceau 3R | 3564-09-8 | substance | cancer | 40 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Potassium bromate | Potassium bromate | 7758-01-2 | substance | cancer | 1 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| Potassium dimethyldithiocarbamate | Potassium dimethyldithiocarbamate | 128-03-0 | substance | developmental | 720 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-03-30 | |
| Pravastatin sodium | Pravastatin sodium | 81131-70-6 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 2000-03-03 | |
| Prednisolone sodium phosphate | Prednisolone sodium phosphate | 125-02-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-08-20 | |
| Primidone | Primidone | 125-33-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-08-20 | |
| Procarbazine | Procarbazine | 671-16-9 | substance | cancer | 0.05 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Procarbazine hydrochloride | Procarbazine hydrochloride | 366-70-1 | substance | cancer | 0.06 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Procarbazine hydrochloride | Procarbazine hydrochloride | 366-70-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Procymidone | Procymidone | 32809-16-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1994-10-01 | |
| Progesterone | Progesterone | 57-83-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Pronamide | Pronamide | 23950-58-5 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1996-05-01 | |
| Propachlor | Propachlor | 1918-16-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2001-02-27 | |
| 1,3-Propane sultone | 1,3-Propane sultone | 1120-71-4 | substance | cancer | 0.3 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Propargite | Propargite | 2312-35-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1994-10-01 | |
| Propargite | Propargite | 2312-35-8 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-06-15 | |
| Propazine | Propazine | 139-40-2 | substance | developmental, female | 100 (oral) µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2016-07-15 | |
| beta-Propiolactone | beta-Propiolactone | 57-57-8 | substance | cancer | 0.05 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Propoxur | Propoxur | 114-26-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2006-08-11 | |
| Propylene glycol mono-t-butyl ether | Propylene glycol mono-t-butyl ether | 57018-52-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2004-06-11 | |
| Propylene oxide | Propylene oxide | 75-56-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-10-01 | |
| Propylthiouracil | Propylthiouracil | 51-52-5 | substance | cancer | 0.7 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Propylthiouracil | Propylthiouracil | 51-52-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Pulegone | Pulegone | 89-82-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2014-04-18 | |
| Pymetrozine | Pymetrozine | 123312-89-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2011-03-22 | |
| Pyridine | Pyridine | 110-86-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2002-05-17 | |
| Pyrimethamine | Pyrimethamine | 58-14-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-01-29 | |
| Quazepam | Quazepam | 36735-22-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1997-08-26 | |
| Quinoline and its strong acid salts | Quinoline and its strong acid salts | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1997-10-24 | CAS column: "---" | ||
| Quizalofop-ethyl | Quizalofop-ethyl | 76578-14-8 | substance | male | 590 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1999-12-24 | |
| Radionuclides | Radionuclides | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1989-07-01 | CAS column: "---" | ||
| Reserpine | Reserpine | 50-55-5 | substance | cancer | 0.06 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Residual (heavy) fuel oils | Residual (heavy) fuel oils | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-10-01 | CAS column: "---" | ||
| Resmethrin | Resmethrin | 10453-86-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2008-07-01 | |
| Resmethrin | Resmethrin | 10453-86-8 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-11-06 | |
| Retinol/retinyl esters, when in daily dosages in excess of 10,000 IU, or 3,000 retinol equivalents. (NOTE: Retinol/retinyl esters are required and essential for maintenance of normal reproductive function. The recommended daily level during pregnancy is 8,000 IU.) | Retinol/retinyl esters, when in daily dosages in excess of 10,000 IU, or 3,000 retinol equivalents. (NOTE: Retinol/retinyl esters are required and essential for maintenance of normal reproductive function. The recommended daily level during pregnancy is 8,000 IU.) | other | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1989-07-01 | CAS column: "---" | ||
| Ribavirin | Ribavirin | 36791-04-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Ribavirin | Ribavirin | 36791-04-5 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 2001-02-27 | |
| Riddelliine | Riddelliine | 23246-96-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2004-12-03 | |
| Rifampin | Rifampin | 13292-46-1 | substance | developmental, female | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 2001-02-27 | |
| Saccharin | Saccharin | 81-07-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | Delisted: April 6, 2001 | until 2001-04-06 |
| Saccharin, sodium | Saccharin, sodium | 128-44-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | Delisted: January 17, 2003 | until 2003-01-17 |
| Safrole | Safrole | 94-59-7 | substance | cancer | 3 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Salted fish, Chinese-style | Salted fish, Chinese-style | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2011-04-29 | CAS column: "---" | ||
| Secobarbital sodium | Secobarbital sodium | 309-43-3 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-10-01 | |
| Sedaxane | Sedaxane | 874967-67-6 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2016-07-01 | |
| Selenium sulfide | Selenium sulfide | 7446-34-6 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Sermorelin acetate | Sermorelin acetate | other | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-08-20 | CAS column: "---" | ||
| Shale-oils | Shale-oils | 68308-34-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-04-01 | |
| Silica, crystalline (airborne particles of respirable size) | Silica, crystalline (airborne particles of respirable size) | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-10-01 | CAS column: "---" | ||
| Silicon carbide whiskers | Silicon carbide whiskers | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2023-11-17 | CAS column: "---" | ||
| Simazine | Simazine | 122-34-9 | substance | developmental, female | 100 (oral) µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2016-07-15 | |
| Sodium dimethyldithiocarbamate | Sodium dimethyldithiocarbamate | 128-04-1 | substance | developmental | 23 (oral) 58 (oral) as a 40% pesticidal formulation µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-03-30 | |
| Sodium fluoroacetate | Sodium fluoroacetate | 62-74-8 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-11-06 | |
| Soots, tars, and mineral oils (untreated and mildly treated oils and used engine oils) | Soots, tars, and mineral oils (untreated and mildly treated oils and used engine oils) | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1987-02-27 | CAS column: "---" | ||
| Spirodiclofen | Spirodiclofen | 148477-71-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2010-10-08 | |
| Spironolactone | Spironolactone | 52-01-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1997-05-01 | |
| Stanozolol | Stanozolol | 10418-03-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1997-05-01 | |
| Sterigmatocystin | Sterigmatocystin | 10048-13-2 | substance | cancer | 0.02 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Streptomycin sulfate | Streptomycin sulfate | 3810-74-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-01-01 | |
| Streptozocin (streptozotocin) | Streptozocin (streptozotocin) | 18883-66-4 | substance | developmental, female, male | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-08-20 | |
| Streptozotocin (streptozocin) | Streptozotocin (streptozocin) | 18883-66-4 | substance | cancer | 0.006 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Strong inorganic acid mists containing sulfuric acid | Strong inorganic acid mists containing sulfuric acid | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2003-03-14 | CAS column: "---" | ||
| Styrene | Styrene | 100-42-5 | substance | cancer | 27 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2016-04-22 | |
| Styrene oxide | Styrene oxide | 96-09-3 | substance | cancer | 4 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-10-01 | |
| Sulfallate | Sulfallate | 95-06-7 | substance | cancer | 4 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Sulfasalazine (Salicylazosulfapyridine) | Sulfasalazine (Salicylazosulfapyridine) | 599-79-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-05-15 | |
| Sulfasalazine (Salicylazosulfapyridine) | Sulfasalazine (Salicylazosulfapyridine) | 599-79-1 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-01-29 | |
| Sulfur dioxidee | Sulfur dioxidee | 7446-09-5 | substance | developmental | 10000 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2011-07-29 | |
| Sulindac | Sulindac | 38194-50-2 | substance | developmental, female | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1999-01-29 | |
| Tacrolimus | Tacrolimus | 104987-11-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2026-07-17 | |
| Talc containing asbestiform fibers | Talc containing asbestiform fibers | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-04-01 | CAS column: "---" | ||
| Tamoxifen and its salts | Tamoxifen and its salts | 10540-29-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1996-09-01 | |
| Tamoxifen citrate | Tamoxifen citrate | 54965-24-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Temazepam | Temazepam | 846-50-4 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Teniposide | Teniposide | 29767-20-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1996-09-01 | |
| Terbacil | Terbacil | 5902-51-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-05-18 | |
| Teriparatide | Teriparatide | 52232-67-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 2015-08-14 | |
| Terrazole | Terrazole | 2593-15-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1994-10-01 | |
| Testosterone and its esters | Testosterone and its esters | 58-22-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Testosterone cypionate | Testosterone cypionate | 58-20-8 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-10-01 | |
| Testosterone enanthate | Testosterone enanthate | 315-37-7 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Tetrabromobisphenol A | Tetrabromobisphenol A | 79-94-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2017-10-27 | |
| 3,3',4,4'-Tetrachloroazobenzene | 3,3',4,4'-Tetrachloroazobenzene | 14047-09-7 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2012-07-24 | |
| 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) | 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) | 1746-01-6 | substance | cancer | 0.000005 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) | 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) | 1746-01-6 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1991-04-01 | |
| 1,1,1,2-Tetrachloroethane | 1,1,1,2-Tetrachloroethane | 630-20-6 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2013-09-13 | |
| 1,1,2,2-Tetrachloroethane | 1,1,2,2-Tetrachloroethane | 79-34-5 | substance | cancer | 3 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-07-01 | |
| Tetrachloroethylene (Perchloroethylene) | Tetrachloroethylene (Perchloroethylene) | 127-18-4 | substance | cancer | 14 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| p-a,a,a-Tetrachlorotoluene | p-a,a,a-Tetrachlorotoluene | 5216-25-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | |
| Tetrachlorvinphos | Tetrachlorvinphos | 22248-79-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2016-05-20 | |
| Tetracycline (internal use) | Tetracycline (internal use) | 60-54-8 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-10-01 | |
| Tetracyclines (internal use) | Tetracyclines (internal use) | other | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---" | ||
| Tetracycline hydrochloride (internal use) | Tetracycline hydrochloride (internal use) | 64-75-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-01-01 | |
| Tetrafluoroethylene | Tetrafluoroethylene | 116-14-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1997-05-01 | |
| Δ9-Tetrahydrocannabinol (Δ9-THC) | Δ9-Tetrahydrocannabinol (Δ9-THC) | other | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2020-01-03 | ||
| Tetrahydrofuran | Tetrahydrofuran | 109-99-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2021-12-17 | |
| Tetranitromethane | Tetranitromethane | 509-14-8 | substance | cancer | 0.059 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-07-01 | |
| Thalidomide | Thalidomide | 50-35-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-07-01 | |
| Thioacetamide | Thioacetamide | 62-55-5 | substance | cancer | 0.1 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| 4,4'-Thiodianiline | 4,4'-Thiodianiline | 139-65-1 | substance | cancer | 0.05 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Thiodicarb | Thiodicarb | 59669-26-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-08-20 | |
| Thioguanine | Thioguanine | 154-42-7 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Thiophanate methyl | Thiophanate methyl | 23564-05-8 | substance | female, male | 600 (oral) µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-05-18 | |
| Thiouracil | Thiouracil | 141-90-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: ; Date listed: 2004-06-11 | |
| Thiourea | Thiourea | 62-56-6 | substance | cancer | 10 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Thorium dioxide | Thorium dioxide | 1314-20-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1987-02-27 | |
| Titanium dioxide (airborne, unbound particles of respirable size) | Titanium dioxide (airborne, unbound particles of respirable size) | other | cancer | 440 (diameters of 10 micrometers or less) 44 (diameters of 8 micrometers or less) µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2011-09-02 | CAS column: "---" | ||
| Tobacco, oral use of smokeless products | Tobacco, oral use of smokeless products | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | CAS column: "---" | ||
| Tobacco smoke | Tobacco smoke | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | CAS column: "---" | ||
| Tobacco smoke (primary) | Tobacco smoke (primary) | other | developmental, female, male | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | CAS column: "---" | ||
| Tobramycin sulfate | Tobramycin sulfate | 49842-07-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Toluene | Toluene | 108-88-3 | substance | developmental | 7000 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1991-01-01 | c: toluene MADL footnote (absorbed dose; see list) | |
| Toluene [Click here for the basis for the removal of female reproductive endpoint effective March 7, 2014] | Toluene [Click here for the basis for the removal of female reproductive endpoint effective March 7, 2014] | 108-88-3 | substance | female | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2009-08-07 | |
| Toluene diisocyanate | Toluene diisocyanate | 26471-62-5 | substance | cancer | 20 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| o-Toluidine | o-Toluidine | 95-53-4 | substance | cancer | 4 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| o-Toluidine hydrochloride | o-Toluidine hydrochloride | 636-21-5 | substance | cancer | 5 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| para-Toluidine | para-Toluidine | 106-49-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1990-01-01 | Delisted: October 29, 1999 | until 1999-10-29 |
| Topiramate | Topiramate | 97240-79-4 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 2015-11-27 | |
| Toxaphene (Polychlorinated camphenes) | Toxaphene (Polychlorinated camphenes) | 8001-35-2 | substance | cancer | 0.6 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Toxins derived from Fusarium moniliforme (Fusarium verticillioides) | Toxins derived from Fusarium moniliforme (Fusarium verticillioides) | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2009-08-07 | CAS column: "---" | ||
| Treosulfan | Treosulfan | 299-75-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1987-02-27 | |
| Triadimefon | Triadimefon | 43121-43-3 | substance | developmental, female, male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-03-30 | |
| Triamterene | Triamterene | 396-01-0 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2014-04-18 | |
| Triazolam | Triazolam | 28911-01-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| S,S,S-Tributyl phosphorotrithioate (Tribufos, DEF) | S,S,S-Tributyl phosphorotrithioate (Tribufos, DEF) | 78-48-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2011-02-25 | |
| Tributyltin methacrylate | Tributyltin methacrylate | 2155-70-6 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-12-01 | |
| Trichlormethine (Trimustine hydrochloride) | Trichlormethine (Trimustine hydrochloride) | 817-09-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1992-01-01 | |
| Trichloroacetic acid | Trichloroacetic acid | 76-03-9 | substance | cancer | 9.9 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2013-09-13 | |
| 1,1,1-Trichloroethane | 1,1,1-Trichloroethane | 71-55-6 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2023-04-21 | |
| Trichloroethylene | Trichloroethylene | 79-01-6 | substance | cancer | 14 (oral) 50 (inhalation) µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Trichloroethylene | Trichloroethylene | 79-01-6 | substance | developmental, male | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2014-01-31 | |
| 2,4,6-Trichlorophenol | 2,4,6-Trichlorophenol | 88-06-2 | substance | cancer | 10 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| 1,2,3-Trichloropropane | 1,2,3-Trichloropropane | 96-18-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1992-10-01 | |
| Trientine hydrochloride | Trientine hydrochloride | 38260-01-4 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 2001-02-27 | |
| Triforine | Triforine | 26644-46-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1999-06-18 | |
| 1,3,5-Triglycidyl-s-triazinetrione | 1,3,5-Triglycidyl-s-triazinetrione | 2451-62-9 | substance | male | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2009-08-07 | Delisted: December 13, 2013 | until 2013-12-13 |
| Trilostane | Trilostane | 13647-35-3 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Trimethadione | Trimethadione | 127-48-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1991-01-01 | |
| 2,4,5-Trimethylaniline and its strong acid salts | 2,4,5-Trimethylaniline and its strong acid salts | group | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1997-10-24 | CAS column: "---" | ||
| Trimethylolpropane triacrylate, technical grade | Trimethylolpropane triacrylate, technical grade | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 2021-12-17 | CAS column: "---" | ||
| Trimethyl phosphate | Trimethyl phosphate | 512-56-1 | substance | cancer | 24 µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1996-05-01 | |
| Trimetrexate glucuronate | Trimetrexate glucuronate | 82952-64-5 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1997-08-26 | |
| TRIM® VX | TRIM® VX | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2018-05-25 | CAS column: "---" | ||
| 2,4,6-Trinitrotoluene (TNT) | 2,4,6-Trinitrotoluene (TNT) | 118-96-7 | substance | cancer | 8.2 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2008-12-19 | |
| Triphenyltin hydroxide | Triphenyltin hydroxide | 76-87-9 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1992-07-01 | |
| Triphenyltin hydroxide | Triphenyltin hydroxide | 76-87-9 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2002-03-18 | |
| Tris(aziridinyl)-p-benzoquinone (Triaziquone) | Tris(aziridinyl)-p-benzoquinone (Triaziquone) | 68-76-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | Delisted: December 8, 2006 | until 2006-12-08 |
| Tris(1-aziridinyl)phosphine sulfide (Thiotepa) | Tris(1-aziridinyl)phosphine sulfide (Thiotepa) | 52-24-4 | substance | cancer | 0.06 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Tris(2-chloroethyl) phosphate | Tris(2-chloroethyl) phosphate | 115-96-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1992-04-01 | |
| Tris(2,3-dibromopropyl)phosphate | Tris(2,3-dibromopropyl)phosphate | 126-72-7 | substance | cancer | 0.3 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) | Tris(1,3-dichloro-2-propyl) phosphate (TDCPP) | 13674-87-8 | substance | cancer | 5.4 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2011-10-28 | |
| Trp-P-1 (Tryptophan-P-1) | Trp-P-1 (Tryptophan-P-1) | 62450-06-0 | substance | cancer | 0.03 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Trp-P-2 (Tryptophan-P-2) | Trp-P-2 (Tryptophan-P-2) | 62450-07-1 | substance | cancer | 0.2 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Trypan blue (commercial grade) | Trypan blue (commercial grade) | 72-57-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1989-10-01 | |
| Unleaded gasoline (wholly vaporized) | Unleaded gasoline (wholly vaporized) | other | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | CAS column: "---" | ||
| Uracil mustard | Uracil mustard | 66-75-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-04-01 | |
| Uracil mustard | Uracil mustard | 66-75-1 | substance | developmental, female, male | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1992-01-01 | |
| Urethane (Ethyl carbamate) | Urethane (Ethyl carbamate) | 51-79-6 | substance | cancer | 0.7 µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-01-01 | |
| Urethane (Ethyl carbamate) | Urethane (Ethyl carbamate) | 51-79-6 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1994-10-01 | |
| Urofollitropin | Urofollitropin | 97048-13-0 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-04-01 | |
| Valproate (Valproic acid) | Valproate (Valproic acid) | 99-66-1 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1987-07-01 | |
| Vanadium pentoxide (orthorhombic crystalline form) | Vanadium pentoxide (orthorhombic crystalline form) | 1314-62-1 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 2005-02-11 | |
| Vinblastine sulfate | Vinblastine sulfate | 143-67-9 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Vinclozolin [basis for listing changed on November 16, 2006] | Vinclozolin [basis for listing changed on November 16, 2006] | 50471-44-8 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1999-08-20 | |
| Vinclozolin | Vinclozolin | 50471-44-8 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1998-05-15 | |
| Vincristine sulfate | Vincristine sulfate | 2068-78-2 | substance | developmental | µg/day (NSRL or MADL) | Listing mechanism: FR; Date listed: 1990-07-01 | |
| Vinyl acetate | Vinyl acetate | 108-05-4 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2025-01-03 | |
| Vinyl bromide | Vinyl bromide | 593-60-2 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 1988-10-01 | |
| Vinyl chloride | Vinyl chloride | 75-01-4 | substance | cancer | 3 µg/day (NSRL or MADL) | Listing mechanism: LC; Date listed: 1987-02-27 | |
| 4-Vinylcyclohexene | 4-Vinylcyclohexene | 100-40-3 | substance | cancer | µg/day (NSRL or MADL) | Listing mechanism: AB; Date listed: 1996-05-01 | |
| 4-Vinylcyclohexene [Click here for the basis for the removal of male reproductive endpoint, effective December 20, 2013 ] | 4-Vinylcyclohexene [Click here for the basis for the removal of male reproductive endpoint, effective December 20, 2013 ] | 100-40-3 | substance | female, male | µg/day (NSRL or MADL) | Listing mechanism: SQE; Date listed: 2009-08-07 |
Official source
Entries are copied exactly as published. Not legal advice; always check the official text.